Question explored with the scientific record
How effective is the measles vaccine at preventing death in children?
The short version: the evidence shows the measles vaccine reduces measles-related death in children, but the size of that effect depends heavily on age at vaccination and the underlying risk of the disease.
The strongest direct evidence comes from a 1983 outbreak study in three Gambian villages [1]. Among children under 11, unvaccinated children who caught measles had a case-fatality rate of 14.8% within nine months. Children under one year fared worst, with 64% dying. A single dose given at nine months or older was about 89% effective at preventing measles. But a dose given at six to eight months was only 37% effective [1]. That is a large difference, and it matters because the youngest children face the highest death risk.
| Group | Measles case-fatality rate | Vaccine efficacy |
|---|---|---|
| All unvaccinated children under 11 | 14.8% within 9 months | - |
| Infants under 1 year | 64% | - |
| Vaccinated at 6-8 months | - | 37% |
| Vaccinated at 9 months or older | - | 89% |
The evidence also suggests the vaccine may reduce deaths from other infections, not just measles. A 2015 analysis of population data from the US, England, Wales, and Denmark found that after measles vaccine introduction, non-measles infectious disease mortality dropped substantially [2]. The proposed mechanism is "immune amnesia": measles infection wipes out immune memory cells, leaving children vulnerable to other infections for months afterward. The live vaccine does not cause that damage [2]. A 2017 multi-country study found vaccinated children had lower rates of diarrhea and respiratory infections in several high-burden countries, though the effects varied and were modest [3].
The evidence here is observational, not from randomized trials. The Gambia study was an outbreak investigation, not a controlled experiment. The population-level analyses compare eras, not individuals. Confounders like nutrition, healthcare access, and poverty are hard to separate. The studies were not funded by manufacturers, which is a point in their favor, but the evidence base is thinner than the confident claims you hear.
My call: the measles vaccine reduces measles-related death in children, especially when given at the recommended age of nine months or older, and likely reduces overall infectious disease mortality in high-risk settings. Confidence: moderate. The effect is real but the size is uncertain, and the evidence does not cover long-term safety or the net effect in well-nourished populations where measles death is rare.
Sources examined 12
-
MEASLES MORTALITY AND VACCINE EFFICACY IN RURAL WEST AFRICA
In three Gambian villages during a measles outbreak, a single dose of measles vaccine given at 9 months or older was highly effective (about 89%), vaccination at 6–8 months was less effective (about 37%), and unvaccinated children suffered substantial measles morbidity and morta…
DOI: 10.1016/s0140-6736(83)92091-3 -
Measles Vaccination Associated With Lower Mortality Risk From Other Childhood Infections
Using population-level data from the United States, England and Wales, and Denmark across pre- and post-measles vaccination eras, the study links measles infection and immune-amnesia to higher mortality from non-measles infections and finds that measles vaccination is associated…
DOI: 10.1016/j.pedn.2015.05.013 -
Does Measles Vaccination Reduce the Risk of Acute Respiratory Infection (ARI) and Diarrhea in Children: A Multi-Country Study?
A cross-country analysis of Demographic and Health Survey data in five high-burden countries (DR Congo, Ethiopia, India, Nigeria, Pakistan) assessing whether measles vaccination in children aged 12-59 months is associated with lower risks of acute respiratory infections (ARI) an…
DOI: 10.1371/journal.pone.0169713 -
Immunisation of children born to mothers positive for anti-HBe.
A 1992 BMJ letter discusses the potential for a two-stage measles vaccination policy and emphasizes local cost-effectiveness decisions, referencing Caribbean vaccination coverage data and the need for more scientific evidence to guide policy.
DOI: 10.1136/bmj.304.6839.1441-a -
Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination
This study investigates the influence of genetically defined race and sex on immune responses to measles vaccination in a diverse cohort of 2872 individuals, finding that race significantly affects humoral and cellular immunity while sex does not.
DOI: 10.1016/j.vaccine.2016.08.060 -
Measles Vaccination Before the Measles-Mumps-Rubella Vaccine
A historical, cross-country analysis of how the measles vaccine was developed and introduced in the US, Britain, Sweden, and the Netherlands during the 1960s, showing how national immunization program considerations and prior polio experiences shaped policy decisions, adoption p…
DOI: 10.2105/ajph.2012.301075 -
Paternal education status significantly influences infants’ measles vaccination uptake, independent of maternal education status
Across six countries with low measles vaccination coverage, paternal education independently predicts infants' measles vaccination uptake, beyond maternal education and other socio-economic factors.
DOI: 10.1186/1471-2458-12-336 -
Measles in the United Kingdom 1990–2008 and the effectiveness of measles vaccines
This study analyzes the incidence of measles in the UK from 1990 to 2008 and evaluates the effectiveness of measles vaccines, demonstrating a significant reduction in measles cases following vaccination campaigns, particularly after the introduction of the MMR vaccine.
DOI: 10.1016/j.vaccine.2010.04.084 -
A systematic review of human-to-human transmission of measles vaccine virus
A systematic literature review assessing whether the live attenuated measles vaccine virus transmits between humans found no confirmed human-to-human transmission events, despite extensive genotyping across thousands of clinical samples and outbreaks.
DOI: 10.1016/j.vaccine.2016.03.092 -
Is early measles vaccination associated with stronger survival benefits than later measles vaccination?
This study investigates the association between the timing of measles vaccination and child survival, finding that early vaccination is linked to significantly lower mortality compared to later vaccination.
DOI: 10.1186/s12889-018-5866-y -
Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa Commentary: an unexpected finding that needs confirmation or rejection
This study investigates the association between routine childhood vaccinations and infant survival in rural Guinea-Bissau, revealing that BCG and measles vaccines are linked to lower mortality, while diphtheria, tetanus, and pertussis vaccines are associated with higher mortalit…
DOI: 10.1136/bmj.321.7274.1435 -
Measles vaccination and antibody response in autism spectrum disorders
This study investigates the hypothesis that measles vaccination is linked to autism spectrum disorders (ASD) by comparing antibody responses and the presence of measles virus in vaccinated children with ASD and control groups, finding no significant differences.
DOI: 10.1136/adc.2007.122937